BRCA2 and neoplasm: Deleterious variants in DNA damage response genes, mainly in lung cancer, are associated with a higher mutational burden (76), as observed in breast carcinomas with DNA damage repair gene variants (77) and in our tumor samples with BRCA1, BRCA2, and PALB2 variants.